Related Experiment Videos
Polymorphisms in the lipopolysaccharide-binding protein and bactericidal/permeability-increasing protein in patients
Jaroslav A Hubacek1, Jan Pitha, Zdena Skodová
1Laboratory for Atherosclerosis Research, Institute of Clinical and Experimental Medicine, Prague, Czech Republic. jaroslav.hubacek@medicon.cz
Abstract:
Gram-negative bacterial infection, namely Chlamydia pneumoniae has been recently discussed as a risk factor for myocardial infarction. The lipopolysaccharide-binding protein (LBP) and the bactericidal/permeability-increasing protein (BPI) play a role in the processes leading to recognition and neutralisation of the Chlamydia pneumoniae and their endotoxins lipopolysaccharides (LPS). LPS interact with plasma LBP, and LBP-LPS complex activates monocytes/macrophages, which can influence the atherosclerotic process. BPI is cytotoxic for Gram-negative bacteria and BPI-LPS complexes do not activate monocytes. We have analysed the polymorphisms in the LBP gene (Gly98-->Cys; Pro436-->Leu) and BPI gene (Lys216-->Glu; PstI polymorphism in intron-5; G545-->C) in 313 patients after myocardial infarction (MI) and in 302 control individuals. Genotype frequencies in the LBP gene and BPI gene did not differ between MI patients and control individuals. Our findings suggest that LBP and BPI polymorphisms do not influence the risk of MI.
Insights
Genetic variations in lipopolysaccharide-binding protein (LBP) and bactericidal/permeability-increasing protein (BPI) do not appear to increase the risk of myocardial infarction (MI). This study found no significant differences in LBP and BPI gene polymorphisms between MI patients and controls.
Area of Science:
- Cardiovascular Disease
- Infectious Disease
- Genetics
Background:
- Gram-negative bacterial infections, such as Chlamydia pneumoniae, are implicated as a risk factor for myocardial infarction (MI).
- Lipopolysaccharide-binding protein (LBP) and bactericidal/permeability-increasing protein (BPI) are key in recognizing and neutralizing bacterial endotoxins like lipopolysaccharides (LPS).
- LPS-LBP complexes activate monocytes, potentially influencing atherosclerosis, while BPI-LPS complexes do not activate monocytes and are cytotoxic to bacteria.
Purpose of the Study:
- To investigate the association between polymorphisms in the LBP and BPI genes and the risk of myocardial infarction.
- To determine if specific genetic variations in LBP and BPI influence susceptibility to MI.
Main Methods:
- Analysis of LBP gene polymorphisms (Gly98-->Cys; Pro436-->Leu) and BPI gene polymorphisms (Lys216-->Glu; PstI; G545-->C).
- Genotyping was performed on 313 patients who had experienced myocardial infarction and 302 healthy control individuals.
- Comparison of genotype frequencies between the myocardial infarction patient group and the control group.
Main Results:
- No significant differences were observed in the genotype frequencies of the analyzed LBP gene polymorphisms between MI patients and controls.
- Similarly, no significant differences were found in the genotype frequencies of the analyzed BPI gene polymorphisms between MI patients and controls.
- The study found no statistically significant association between the investigated LBP and BPI gene polymorphisms and the risk of myocardial infarction.
Conclusions:
- The findings suggest that the studied polymorphisms in the LBP and BPI genes do not play a significant role in modulating the risk of myocardial infarction.
- Further research may be needed to explore other genetic or environmental factors contributing to MI risk in the context of Chlamydia pneumoniae infection.